Myristicin is an orally bioavailable serotonin receptor antagonist and a weak monoamine oxidase (MAO) inhibitor. It exhibits anti-cancer effects on gastric cancer cells by inhibiting the EGFR/ERK signaling pathway. As the primary component of nutmeg essential oil, Myristicin possesses anti-cancer, anti-proliferative, antibacterial, anti-inflammatory, and apoptosis-inducing properties.
- Orally bioavailable serotonin receptor antagonist
- Weak monoamine oxidase (MAO) inhibitor
- Inhibits EGFR/ERK signaling pathway
- Main component of nutmeg essential oil
- Exhibits anti-cancer, anti-proliferative, antibacterial, and anti-inflammatory properties
- Induces apoptosis in gastric cancer cells
- Reduces cell cycle protein expression
- Increases Bax expression and activates caspase enzyme
- Targets EGFR, ERK, and 5-HT Receptor